Sotera Health Company (SHC) vs Travere Therapeutics, Inc. (TVTX)
A side-by-side comparison of Sotera Health Company and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
SHC
Sotera Health Company
$18.36HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
TVTX
Travere Therapeutics, Inc.
$55.86HealthcareDelayed quote: Oct 6, 2026, 2:35 PM EDT
Total return — SHC vs TVTX
growth of $100 · dividends reinvested · last 6ySHC -26.1% (-4.9%/yr)TVTX +136.7% (+15.4%/yr)TVTX compounded faster over this window
SHC TVTX
SHC vs TVTX: by the numbers
- •SHC is the larger company ($5.23B vs $5.19B market cap).
- •SHC is profitable (13.44% net margin) while TVTX runs a net loss (-7.35%).
- •TVTX grew revenue faster over the past five years (23.71% vs 6.66% CAGR).
Metrics side by side
Valuation
| Metric | SHC | TVTX |
|---|---|---|
| P/E ratio | 32.07 | N/A |
| Forward P/E | 18.64 | N/A |
| P/S ratio | 4.30 | 8.78 |
| P/B ratio | 7.86 | 211.81 |
| EV / EBITDA | 12.48 | 248.47 |
| FCF yield | 2.15% | 0.99% |
Profitability
| Metric | SHC | TVTX |
|---|---|---|
| Gross margin | 54.72% | 94.41% |
| Operating margin | 36.24% | -6.84% |
| Net margin | 13.44% | -7.35% |
| ROE | 24.56% | -177.24% |
| ROIC | 8.80% | -6.19% |
Growth (annualized)
| Metric | SHC | TVTX |
|---|---|---|
| Revenue CAGR (5Y) | 6.66% | 23.71% |
| FCF CAGR (5Y) | 17.34% | N/A |
| Total return CAGR (5Y) | -6.39% | 17.83% |
Frequently asked
- Which has grown faster, SHC or TVTX?
- Over the past five years, TVTX grew revenue faster — SHC at a 6.66% CAGR versus TVTX at 23.71%.
- Is SHC or TVTX more profitable?
- SHC runs the higher net margin — SHC at 13.44% versus TVTX at -7.35%.
- How have SHC and TVTX total returns compared?
- Over the past 5 years, SHC delivered -6.39% and TVTX delivered 17.83% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Sotera Health P/E ratioSotera Health ROETravere Therapeutics ROESotera Health operating marginTravere Therapeutics operating marginSotera Health revenue growthTravere Therapeutics revenue growthSotera Health free cash flowTravere Therapeutics free cash flow
Sotera Health & Travere Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.